Nomura Holdings, Inc.
NMR · NYSE
10/27/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.15 | -0.33 | 2.17 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 0.00 | 173.06 | 292.17 | 212.12 |
| Quality | ||||
| ROIC | 0.00% | 0.27% | 0.18% | 0.25% |
| Gross Margin | 42.03% | 45.25% | 36.18% | 39.71% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 10.38% | 16.96% | 24.69% | 31.96% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 155.49 | 264.28 | 192.66 |
| Interest Coverage | 0.21 | 0.25 | 0.16 | 0.20 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -114.12 | -47.39 | -64.21 |